These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 32055997)
1. Two novel cases further expand the phenotype of TOR1AIP1-associated nuclear envelopathies. Lessel I; Chen MJ; Lüttgen S; Arndt F; Fuchs S; Meien S; Thiele H; Jones JR; Shaw BR; Crossman DK; Nürnberg P; Korf BR; Kubisch C; Lessel D Hum Genet; 2020 Apr; 139(4):483-498. PubMed ID: 32055997 [TBL] [Abstract][Full Text] [Related]
2. Combined loss of LAP1B and LAP1C results in an early onset multisystemic nuclear envelopathy. Fichtman B; Zagairy F; Biran N; Barsheshet Y; Chervinsky E; Ben Neriah Z; Shaag A; Assa M; Elpeleg O; Harel A; Spiegel R Nat Commun; 2019 Feb; 10(1):605. PubMed ID: 30723199 [TBL] [Abstract][Full Text] [Related]
3. Selective loss of a LAP1 isoform causes a muscle-specific nuclear envelopathy. Lornage X; Mallaret M; Silva-Rojas R; Biancalana V; Giovannini D; Dieterich K; Saker S; Deleuze JF; Wuyam B; Laporte J; Böhm J Neurogenetics; 2021 Mar; 22(1):33-41. PubMed ID: 33405017 [TBL] [Abstract][Full Text] [Related]
4. Mackels L; Liu X; Bonne G; Servais L Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108075 [TBL] [Abstract][Full Text] [Related]
5. Mutation in TOR1AIP1 encoding LAP1B in a form of muscular dystrophy: a novel gene related to nuclear envelopathies. Kayman-Kurekci G; Talim B; Korkusuz P; Sayar N; Sarioglu T; Oncel I; Sharafi P; Gundesli H; Balci-Hayta B; Purali N; Serdaroglu-Oflazer P; Topaloglu H; Dincer P Neuromuscul Disord; 2014 Jul; 24(7):624-33. PubMed ID: 24856141 [TBL] [Abstract][Full Text] [Related]
6. Identification of a novel human LAP1 isoform that is regulated by protein phosphorylation. Santos M; Domingues SC; Costa P; Muller T; Galozzi S; Marcus K; da Cruz e Silva EF; da Cruz e Silva OA; Rebelo S PLoS One; 2014; 9(12):e113732. PubMed ID: 25461922 [TBL] [Abstract][Full Text] [Related]
7. Genetic mutations strengthen functional association of LAP1 with DYT1 dystonia and muscular dystrophy. Rebelo S; da Cruz E Silva EF; da Cruz E Silva OA Mutat Res Rev Mutat Res; 2015; 766():42-7. PubMed ID: 26596547 [TBL] [Abstract][Full Text] [Related]
8. Loss of the Nuclear Envelope Protein LAP1B Disrupts the Myogenic Differentiation of Patient-Derived Fibroblasts. Kayman Kürekçi G; Acar AC; Dinçer PR Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362402 [TBL] [Abstract][Full Text] [Related]
9. Severe dystonia, cerebellar atrophy, and cardiomyopathy likely caused by a missense mutation in TOR1AIP1. Dorboz I; Coutelier M; Bertrand AT; Caberg JH; Elmaleh-Bergès M; Lainé J; Stevanin G; Bonne G; Boespflug-Tanguy O; Servais L Orphanet J Rare Dis; 2014 Nov; 9():174. PubMed ID: 25425325 [TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of iPSC lines from two nuclear envelopathy patients with a homozygous nonsense mutation in the TOR1AIP1 gene. Ben-Haim Y; Armon L; Fichtman B; Epshtein I; Spiegel R; Harel A; Urbach A Stem Cell Res; 2021 Oct; 56():102539. PubMed ID: 34560421 [TBL] [Abstract][Full Text] [Related]
11. Mutation in TOR1AIP1 encoding LAP1B in a form of muscular dystrophy: a novel gene related to nuclear envelopathies. Sewry CA; Goebel HH Neuromuscul Disord; 2014 Dec; 24(12):1122. PubMed ID: 25193335 [No Abstract] [Full Text] [Related]
12. A TOR1AIP1 variant segregating with an early onset limb girdle myasthenia-Support for the role of LAP1 in NMJ function and disease. Malfatti E; Catchpool T; Nouioua S; Sihem H; Fournier E; Carlier RY; Cardone N; Davis MR; Laing NG; Sternberg D; Ravenscroft G Neuropathol Appl Neurobiol; 2022 Feb; 48(1):e12743. PubMed ID: 34164833 [TBL] [Abstract][Full Text] [Related]
13. Muscular involvement and tendon contracture in limb-girdle muscular dystrophy 2Y: a mild adult phenotype and literature review. Feng X; Wu J; Xian W; Liao B; Liao S; Yao X; Zhang W BMC Musculoskelet Disord; 2020 Sep; 21(1):588. PubMed ID: 32873274 [TBL] [Abstract][Full Text] [Related]
14. Quantitative proteome analysis of LAP1-deficient human fibroblasts: A pilot approach for predicting the signaling pathways deregulated in LAP1-associated diseases. Pereira CD; Espadas G; Martins F; Bertrand AT; Servais L; Sabidó E; Chevalier P; da Cruz E Silva OAB; Rebelo S Biochem Biophys Rep; 2024 Sep; 39():101757. PubMed ID: 39035020 [TBL] [Abstract][Full Text] [Related]
15. Gene co-expression network analysis of dysferlinopathy: Altered cellular processes and functional prediction of TOR1AIP1, a novel muscular dystrophy gene. Cali-Daylan AE; Dincer P Neuromuscul Disord; 2017 Mar; 27(3):269-277. PubMed ID: 28110863 [TBL] [Abstract][Full Text] [Related]
17. TOR1AIP1 as a cause of cardiac failure and recessive limb-girdle muscular dystrophy. Ghaoui R; Benavides T; Lek M; Waddell LB; Kaur S; North KN; MacArthur DG; Clarke NF; Cooper ST Neuromuscul Disord; 2016 Aug; 26(8):500-3. PubMed ID: 27342937 [TBL] [Abstract][Full Text] [Related]
18. Mouse models of the nuclear envelopathies and related diseases. Preface. Stewart CL Curr Top Dev Biol; 2014; 109():xi-xiii. PubMed ID: 24947241 [No Abstract] [Full Text] [Related]